Meeting News

More data needed on Xeljanz, venous thromboembolism risk in ulcerative colitis

November 19, 2019
SAN ANTONIO — A post hoc analysis evaluating the safety of Xeljanz in ulcerative colitis revealed comparable incidence rates of pulmonary…
Meeting News

Geriatric IBD mortality trend highlights need for ‘more standardized guidelines’

November 12, 2019
SAN ANTONIO — The odds of inpatient mortality were nearly four times higher among geriatric adults than adults aged younger than 75 years who…
Meeting News

Entyvio exhibits favorable real-world safety profile in biologic-naive IBD patients

November 8, 2019
SAN ANTONIO — Entyvio was associated with significantly fewer serious adverse events and serious infections compared with anti-TNF therapy in…
Meeting News

Mesalamine most commonly prescribed Crohn’s disease treatment among older patients

November 6, 2019
SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than twice as likely to receive…
Meeting NewsVideo

VIDEO: How to identify, manage patients with high-risk ulcerative colitis

November 5, 2019
SAN ANTONIO — In this video from the American College of Gastroenterology Annual Meeting, David T. Rubin, MD, section chief of…
FDA News

FDA approves Stelara for ulcerative colitis

October 22, 2019
The FDA on Monday approved Stelara for the treatment of adults with moderately to severely active ulcerative colitis, according to a press release…
Meeting News

Adult endoscopic scores accurately assess pediatric ulcerative colitis

October 19, 2019
CHICAGO — Two endoscopic scoring indices originally designed for use in adults are reliable for the assessment of endoscopic in children with…
In the Journals

Introduction of anti-TNF has reduced colectomies, corticosteroid use in UC

October 3, 2019
Since the introduction of anti-TNF therapy in 2004, colectomy rates and corticosteroid use has gone down among patients with ulcerative colitis in…

Q&A: VARSITY, UNIFI add to the armamentarium for ulcerative colitis

September 25, 2019
Physicians have an array of biologic agents available to treat patients with ulcerative colitis, but it is still unknown which therapies are…

EC approves expanded use of Stelara for moderately to severely active ulcerative colitis

September 6, 2019
The European Commission on Wednesday approved the expanded use of Stelara for adults with moderately to severely active ulcerative colitis, according…